Skip to main content
SpringerLink
Log in

A simple strategy to improve patient adherence to outpatient fecal occult blood testing

  • Brief Report
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Poor patient adherence reduces the effectiveness of fecal occult blood testing for colon cancer. Patients at the inner-city clinic involved in the study have historically completed only one-third of the tests administered to them. The authors studied three ways of returning test kits (by hand, by mail, and by mail with prepaid postage). Among 146 randomly assigned patients, the completion rates were 37%, 57%, and 71%, respectively. The difference was significant between the first and third groups (p=0.003), and the cost was less for the third group ($1.71 vs $2.24 per completed test). The authors recommend that clinics serving indigent populations use postage-paid return envelopes with fecal occult blood testing to improve its effectiveness and save money.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gilbertson VA, McHugh R, Schuman L, Williams SE. The earlier detection of colorectal cancer. A preliminary report of the results of the Occult Blood Study. Cancer. 1980;45:2899–901.

    Article  Google Scholar 

  2. Winawer SJ, Fath RB Jr, Schottenfeld D, Herbert E. Screening for cancer. In: Miller AB (ed). Screening for Cancer. Orlando, FL: Academic Press, 1985:347–66.

    Google Scholar 

  3. Kronborg O, Fenger C, Sondergarrd O, Pederson KM, Olsen J. Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol. 1987;22:677–86.

    PubMed  CAS  Google Scholar 

  4. Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer. 1988;62:645–51.

    Article  PubMed  CAS  Google Scholar 

  5. Hardcastle JD, Thomas WM, Chamberlain J, et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet. 1989;1:1160–4.

    Article  PubMed  CAS  Google Scholar 

  6. Selby JV, Friedman GD, Quesenberry CP Jr. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med. 1993;118:1–6.

    PubMed  CAS  Google Scholar 

  7. Elwood TW, Erickson A, Lieberman S. Comparative educational approaches to screening for colorectal cancer. Am J Public Health. 1978;68:135–8.

    PubMed  CAS  Google Scholar 

  8. Marcus AC, Crane LA, Kaplan CP, et al. Improving adherence to screening follow-up among women with abnormal Pap smears. Results from a large clinic-based trial of three intervention strategies. Med Care. 1988;30:216–30.

    Article  Google Scholar 

  9. Eddy DM. Screening for colorectal cancer. Ann Intern Med. 1990;19:502–14.

    Google Scholar 

  10. Sontag SJ, Durczak C, Aranha GV, Chejfec G, Frederick W, Greenlee HB. Fecal occult blood screening for colorectal cancer in a Veterans Administration hospital. Am J Surg. 1983;145:89–93.

    Article  PubMed  CAS  Google Scholar 

  11. Thompson RS, Michnick ME, Gray J, Friedlander K, Gilson B. Maximizing compliance with Hemoccult screening for colon cancer in clinical practice. Med Care. 1986;24:904–14.

    Article  PubMed  CAS  Google Scholar 

  12. Hoogewerf PE, Hislop TG, Morrison BJ, Burns SD, Sizto R. Patient compliance with screening for fecal occult blood in family practice. Can Med Assoc J. 1987;137:195–8.

    CAS  Google Scholar 

  13. Myers RE, Trock BJ, Lerman C, Wolf T, Ross E, Engstrom PF. Adherence to cancer screening in an HMO population. Prev Med. 1990;19:502–14.

    Article  PubMed  CAS  Google Scholar 

  14. Lallemand RC, Vakil PA, Pearson P, Box V. Screening for asymptomatic bowel cancer in general practice. Br Med J. 1984;288:31–3.

    Article  CAS  Google Scholar 

  15. Adamsen S, Kronborg O. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol. 1984;19:531–4.

    PubMed  CAS  Google Scholar 

  16. Klaaborg K, Madsen MS, Sondergaard O, Kronborg O. Participation in mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol. 1986;21:1180–4.

    PubMed  CAS  Google Scholar 

  17. Macrae FA, St. John DJB, Ambikapathy A, Sharpe K, Garner JF, the Ballarat General Practitioner Research Group. Factors affecting compliance in colorectal cancer screening. Results of a study performed in Ballarat. Med J Australia. 1986;144:621–3.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Kaiser Foundation Health Plan of Colorado, 10400 East Dakota Avenue, 80231-5199, Denver, CO

    John D. Freedman MD

Authors
  1. John D. Freedman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charlene K. Mitchell MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received from the Division of General Internal Medicine, Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Freedman, J.D., Mitchell, C.K. A simple strategy to improve patient adherence to outpatient fecal occult blood testing. J Gen Intern Med 9, 462–464 (1994). https://doi.org/10.1007/BF02599066

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02599066

Key words

Search

Navigation